John Trottier

Birchview Capital, Lp

Assets Managed

$175.664M

Holdings

Last Quarter

2026 - Q1

Filed Date

1mo ago

Growth Rate

2.85%(2Q avg: 15.91%)

Sustained Growth

3 quarters

Portfolio positions

This chart displays the top 10 holdings in Birchview Capital, Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 73 positions.

Assets under management

The assets under management (AUM) of Birchview Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 175.664M in assets, with a quarterly growth rate of 2.85% and a 2-quarter average growth rate of 15.91%. The portfolio is managed by John Trottier, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
KLAC Kla Corp Recent Activity Decreased -9.13%	16.67%	$29.276M 19,883 shares@ $1472.41 avg price	Decreased -9.13%
BMY Bristol-myers Squibb Co Recent Activity Increased 1.14%	10.58%	$18.575M 306,268 shares@ $60.65 avg price	Increased 1.14%
CMPX Compass Therapeutics Inc Recent Activity Decreased -7.97%	4.42%	$7.754M 1.466M shares@ $5.29 avg price	Decreased -7.97%
LRCX Lam Research Corp Recent Activity Decreased -10.73%	4.38%	$7.692M 36,000 shares@ $213.66 avg price	Decreased -10.73%
STOK Stoke Therapeutics Inc Recent Activity Decreased -19.23%	3.9%	$6.838M 210,000 shares@ $32.56 avg price	Decreased -19.23%
OVV Ovintiv Inc Recent Activity	3.64%	$6.381M 107,500 shares@ $59.36 avg price
NTLA Intellia Therapeutics Inc Recent Activity Increased 41.22%	3.26%	$5.71M 445,400 shares@ $12.82 avg price	Increased 41.22%
GPCR Structure Therapeutics Inc Recent Activity Increased 11.12%	2.75%	$4.82M 100,000 shares@ $48.2 avg price	Increased 11.12%
SLDB Solid Biosciences Inc Recent Activity Decreased -11.32%	2.57%	$4.507M 625,980 shares@ $7.2 avg price	Decreased -11.32%
PRTA Prothena Corp Plc Recent Activity Increased 1.82%	2.49%	$4.364M 449,019 shares@ $9.73 avg price	Increased 1.82%

1-10 of 73